SOX2 and sarcoma: This hypothesis is further bolstered by the high expression of SOX2 in DSRCT relative to other fusion sarcomas and the finding that extraperitoneal metastatic DSRCT samples express higher levels of stemness markers (SOX2 and NANOG) than intraperitoneal DSRCT tumors [8].